BioPharmaStock
HomeAsk About StockNewsIdeasHistoryFDA DesignationsElite Program

QTEX

No price yet

Announcements

Nothing here yet

Daily updates

  • QTREX Quantum reported standalone 20 mK trial results for its additively manufactured cryogenic interconnect line, demonstrating over 100 dB channel-to-channel isolation, phase alignment, reduced insertion loss, and stable performance through thermal and mechanical flex cycles. The results support its quantum networking roadmap as management pursues a definitive agreement with its evaluation partner.Oct 1, 2026

FDA designations

Nothing here yet

News

  • QTREX's patent-pending technology achieved the first direct conversion of 3D-printed insulation into graphene-like carbon to protect quantum processorsAug 20, 2026

    Bio Pharma Stock

    Where Science Meets Investing.

    BioPharmaStock is a specialized biopharmaceutical investment intelligence company focused exclusively on publicly traded biotechnology and pharmaceutical companies. Our research team continuously analyzes clinical trials, FDA regulatory events, scientific publications, corporate developments, and market catalysts to deliver timely research and exclusive insights for investors seeking opportunities in one of the world's most knowledge-intensive sectors.

    ALNJAM ALAALI SOFTWARE DESIGN CO. L.L.C, UAE, Abu Dhabi

    BioPharmaStock LogoBioPharmaStock Logo

    Quick Links

    • Home
    • Ask About Stock
    • News
    • Ideas
    • History
    • FDA Designations
    • Elite Program

    Contact Us

    Email: info@biopharmastock.com

    Phone: +971 50 936 3328

    Join Our Community→

    Follow Us

    Get the App

    Instant notifications on your phone

    Download on theApp StoreGet it onGoogle Play

    © 2026 Bio Pharma Stock. All rights reserved. Policy